久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

  • PLx Pharma Receives FDA Approval of SNDAs for Two VAZALORE Dosages americanpharmaceuticalreview
    March 04, 2021
    PLx Pharma announced the U.S. Food and Drug Administration (FDA) approved supplemental new drug applications (sNDAs) for its lead products, VAZALORE? 325 mg and VAZALORE? 81 mg (referred to together as VAZALORE), the first novel, liquid-filled aspirin ...
  • PLx Pharma Submits sNDAs for VAZALORE americanpharmaceuticalreview
    November 26, 2020
    PLx Pharma announced two chemistry and manufacturing control (CMC) supplemental New Drug Applications (sNDAs), one for VAZALORE 325 mg and one for VAZALORE 81 mg dose (referred to together as VAZALORE), have been submitted to the U.S. Food and Drug ...
PharmaSources Customer Service